Latest filing published 31 Aug 2022 for Everest Medicines Ltd..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Blanchard Kerry Levan: trading record in brief
This profile gathers the share dealings of Blanchard Kerry Levan in Everest Medicines Ltd. Over a trading history stretching from 9 October 2020 to 26 August 2022, the count stands at 6 filings.
On the market, this insider has only ever bought: 3 purchases. No amount is published for 3 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show 3 purchases and no sales.
The latest filing, published on 31 August 2022, reports a transaction in Everest Medicines Ltd. The most recent open-market purchase was published on 11 July 2022, 1,582 days ago. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Companies and markets linked to Blanchard Kerry Levan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,873,499 sharesShareXHKGHKEX:DA20220831E00269
- 2,500,000 sharesShareXHKGHKEX:DA20220711E00529Canonical exit: 30 Jun 2022 (T+90)
- 160,075 sharesShareXHKGHKEX:DA20220705E00525
- 640,303 sharesShareXHKGHKEX:DA20220705E00524Canonical exit: 12 Oct 2021 (T+90)
- 1,483,196 sharesShareXHKGHKEX:DA20220309E00257Canonical exit: 12 Oct 2021 (T+90)
- 3,250,000 sharesShareXHKGHKEX:DA20201023E00386
6 of 6 declarations